Angewandte Chemie (International ed. in English)

Special Lipids Made from Vitamin A Help mRNA Cancer Vaccines Target Antigen Production in the Spleen

Updated

Abstract

AT4-13CRA LNPs achieved approximately 15.1-fold higher splenic expression compared to a tested formulation.

  • Effective mRNA cancer vaccination relies on productive antigen expression in lymphoid antigen-presenting cells.
  • The study developed a library of 40 retinoic-acid-derived ionizable lipids (RAILs) to enhance mRNA expression.
  • AT4-13CRA LNPs were identified as the most effective formulation based on spleen-to-liver reporter expression ratios.
  • The enhanced expression was linked to reduced retention of mRNA in lysosomes and lower activation of certain inflammatory pathways.
  • In mouse models, AT4-13CRA LNPs promoted effective responses in splenic macrophages and dendritic cells, resulting in stronger CD8+ T-cell and antibody responses.
  • These findings suggest a method for creating targeted mRNA vaccines that focus on spleen-specific immune responses.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free